Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers
Clinical trial NCT05621655 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05621655
- Sponsor
- MAXVAX Biotechnology Limited Liability Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-08
- Primary completion
- 2023-04-29
- Enrollment
- 1512
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.